Merck & Co., Inc. (NYSE:MRK) July 15, 2015 0

Stock Price
View Comparative Chart →
Full Screen
1D
Chart
Select Tool
  • O:
  • H:
  • V:
  • C:
  • L:
savecancel
(right-click to delete)
--
Implied Price
UNDERVALUED
52.49 65.69
A Price as of Close Jul 14 58.19 USD
B CapitalCube Median Implied Price 63.91 USD * CapitalCube Price is over trading range * CapitalCube Price is below trading range
CapitalCube Estimate Range 62.13 - 65.69 USD NA
52 Week Range 52.49 - 63.62 USD
Earnings Momentum Score
 0  100
A Earnings Score (MRK) 17.65
B Earnings Score(Peer Median) 42.92
Latest Filing date March 31, 2015
Fundamental Score
 0  100
A Fundamental Score (MRK) 56
B Fundamental Score(Peer Median) 56
Dividend Score
 0  100
A Dividend Quality Score (MRK) 42
B Dividend Quality Score (Peer Median) 58
Dividend Yield
1.76 5.86
A Dividend Yield (MRK) 3.08
B Dividend Yield (Peer Median) 2.23
Sentiment
MRK
50t
15m
1h

Time your trades.

Real-time sentiment based on short, mid, and long term trends.

Analysis
Unlock The Complete Analysis →

Fundamental Analysis

Likely Corporate Actions

Dividend Quality

Accounting Red Flags

Price History

Peers

FA Score

DQ Score

close

52 week range

58.19

52.49

63.62

USD

35.08

27.51

35.53

USD

99.78

95.10

109.49

USD

70.06

47.55

70.28

USD

88.76

60.14

90.18

USD

53.34

43.57

57.42

USD

43.34

41.19

53.82

USD

293.52

257.20

320.50

USD

105.92

84.17

105.99

USD

159.32

114.93

173.60

USD

Company Profile

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company operates through the following segments: Pharmaceutical, Animal Health and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The company sells these products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Its vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The company sells these vaccines primarily to physicians, wholesalers, physician distributors and government entities. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines, which it sells to veterinarians, distributors and animal producers. The Alliances segment includes revenue from the company relationship with AstraZeneca LP. The company was founded in 1851 and is headquartered in Kenilworth, NJ.

Closing Stock Price

USD 58.19

As of Date

July 14, 2015

One Year Performance

0.02%

One Month Performance

0.55%

Industry Group

Pharmaceuticals: Major

52 wk. Range

USD 52.49 - USD 63.62

Market Cap (Millions)

USD 164,399.67

Total Shares Outstanding

2828.388471
Latest Filing Dates

Annual

December 31, 2014

Semi Annual

N/A

Quarterly

March 31, 2015

Next Release Date

July 28, 2015

Filing Currency

USD

Listed Exchange

NYSE
Peers


Latest Tweets via StockTwits
MRK
Please login to stocktwits
Post your response
share chart (wait for to display dialog to show)
Message must be no longer than 140 characters.
21
share page
Please Login to see your stream! No Twits! Your stream is empty No Twits for MRK!

Closing Stock Price

USD 58.19

As of Date

July 14, 2015

One Year Performance

0.02%

One Month Performance

0.55%

Industry Group

Pharmaceuticals: Major

52 wk. Range

USD 52.49 - USD 63.62

Market Cap (Millions)

USD 164,399.668

Total Shares Outstanding (Millions)

2,828.39
Latest Filing Dates

Annual

December 31, 2014

Semi Annual

N/A

Quarterly

March 31, 2015

Next Release Date

July 28, 2015

Filing Currency

USD

Listed Exchange

NYSE
Register
to customize peers
Peer analysis →